Narayanam Srikanth Selected Research

Ashwagandha

1/2022	Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.
1/2022	Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.
11/2021	Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis.
6/2021	Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Narayanam Srikanth Research Topics

Disease

8	COVID-19 06/2022 - 04/2020
1	Anosmia 10/2021
1	Nasal Obstruction 10/2021
1	Headache (Headaches) 10/2021
1	Essential Hypertension 07/2021

Drug/Important Bio-Agent (IBA)

4	AshwagandhaIBA 01/2022 - 06/2021
3	Ayush 64IBA 06/2022 - 04/2020
2	COVID-19 VaccinesIBA 01/2022 - 01/2022
1	VaccinesIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2021
1	1- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphtholIBA 07/2021
1	TabletsIBA 06/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	AntibodiesIBA 06/2021
1	Pharmaceutical PreparationsIBA 07/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020

Therapy/Procedure

1	Chemoprevention 11/2021
1	Therapeutics 10/2021
1	CARE protocol 06/2021